| 注册
首页|期刊导航|中国医药科学|依托考昔和美洛昔康在治疗膝骨关节炎中的可行性对比

依托考昔和美洛昔康在治疗膝骨关节炎中的可行性对比

陈春毅

中国医药科学Issue(11):77-79,3.
中国医药科学Issue(11):77-79,3.

依托考昔和美洛昔康在治疗膝骨关节炎中的可行性对比

Feasibility comparison of etoricoxib and meloxicam in treatment of knee osteoarthritis

陈春毅1

作者信息

  • 1. 广东省潮州市人民医院风湿内科,广东潮州 521000
  • 折叠

摘要

Abstract

Objective To evaluate the feasibility of etoricoxib and meloxicam in treatment of knee osteoarthritis. Methods100 cases of patients with knee osteoarthritis from March 2014 to December 2014 were chosen to research,and were divided into experimental and control group,experimental group was treated with etoricoxib,control group was treated with meloxicam,Womac osteoarthritis index,severity index and curative effects between two group were compared.Results The curative rate of control group was 74.00%,while the experimental group was 92.00%,there were statistically significant differences between groups (P<0.05).Womac osteoarthritis index and severity index between two group had no significant statistical difference before treatment,and were all decreased obviously after treatment,with great statistical difference comparing to before(P<0.05).Womac osteoarthritis index and severity index of experimental group were lower than that of the control group after 1 and 3 weeks' treatments,difference were statistically significant(P<0.05).Conclusion Compared with meloxicam,etoricoxib has quicker speed of onset in treatment of knee osteoarthritis,and better clinical symptoms improved better effect,worth be application in clinical treatment.

关键词

膝骨关节炎/美洛昔康/依托考昔/疗效

Key words

Knee osteoarthritis/Meloxicam/Etoricoxib/Curative effect

分类

医药卫生

引用本文复制引用

陈春毅..依托考昔和美洛昔康在治疗膝骨关节炎中的可行性对比[J].中国医药科学,2015,(11):77-79,3.

中国医药科学

2095-0616

访问量0
|
下载量0
段落导航相关论文